Search for the latest updates on diabetes
News
Disruptor 50: No. 29 Intarcia Therapeutics CNBC - 54 minutes
Investors believe Intarcia's drug-delivery system could very well upend the $55 billion worldwide market for treating Type-2 diabetes.
Manage alerts · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Search. |
No comments:
Post a Comment